Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes
- 1 January 2024
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 52 (05) , 1275-1301
Abstract
Inflammatory bowel disease (IBD) refers to long-term medical conditions that involve inflammation of the digestive tract, and the global incidence and prevalence of IBD are on the rise. Gut microbes play an important role in maintaining the intestinal health of the host, and the occurrence, development, and therapeutic effects of IBD are closely related to the structural and functional changes of gut microbes. Published studies have shown that the natural products from traditional Chinese medicine have direct or indirect regulatory impacts on the composition and metabolism of the gut microbes. In this review, we summarize the research progress of several groups of natural products, i.e., flavonoids, alkaloids, saponins, polysaccharides, polyphenols, and terpenoids, for the therapeutic activities in relieving IBD symptoms. The role of gut microbes and their intestinal metabolites in managing the IBD is presented, with focusing on the mechanism of action of those natural products. Traditional Chinese medicine alleviated IBD symptoms by regulating gut microbes, providing important theoretical and practical basis for the treatment of variable inflammatory intestinal diseases.Keywords
Funding Information
- The National Natural Science Foundation of China (61671098)
This publication has 96 references indexed in Scilit:
- The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapyBiomedicine & Pharmacotherapy, 2023
- The genetics of non-monogenic IBDHuman Genetics, 2023
- Dihydroartemisinin ameliorates dextran sulfate sodium induced inflammatory bowel diseases in miceBioorganic Chemistry, 2020
- Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitisApplied Microbiology and Biotechnology, 2020
- The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor ReceptorClinical Reviews in Allergy & Immunology, 2020
- Inflammatory bowel disease: between genetics and microbiotaMolecular Biology Reports, 2020
- Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and SymbiosisCell Host & Microbe, 2019
- Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cellsJournal of Leukocyte Biology, 2019
- Innate and adaptive immunity in inflammatory bowel diseaseAutoimmunity Reviews, 2014
- Desulfovibrio Bacterial Species Are Increased in Ulcerative ColitisDiseases of the Colon & Rectum, 2010